The AP-GELP Study: A Clinical Trial on the Effects of Apremilast in Female Genital Erosive Lichen Planus

NCT03656666 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Lichen Planus of Vulva
Female Genital Disease

Interventions

DRUG: Apremilast
DRUG: Placebo

Sponsor

Oslo University Hospital

Collaborators

[object Object]
[object Object]